文献速递脑血管病

急性缺血性卒中串联病变患者急诊颈动脉支架置入:SECURIS研究1年随访结果

Emergent Carotid Artery Stenting in Patients With Acute Ischemic Stroke With Tandem Lesions: One-Year Follow-Up Results From the SECURIS Study.
PubMed 文献 · Neurology · 2025-09-12

SECURIS研究基于西班牙加泰罗尼亚2017至2023年前瞻性强制人群登记数据,纳入578例大血管闭塞伴同侧颈内动脉≥50%粥样硬化性狭窄并接受血管内治疗的患者,比较急诊颈动脉支架置入(eCAS)与非eCAS的90天和1年结局。eCAS与90天及1年功能结局改善相关,且不增加出血转化风险或死亡率。

要点

  • eCAS与90天和1年mRS评分改善独立相关,且不增加症状性出血或死亡风险。
  • eCAS组成功再通率显著更高,获益在中度(50%-69%)和重度(≥70%)颈动脉狭窄亚组中一致。
  • eCAS组24小时内接受双联抗血小板治疗者90天良好功能结局比例更高。

核心结论

  • 在急性缺血性卒中串联病变接受血管内治疗的患者中,急诊颈动脉支架置入与更好的中期和长期功能结局相关,且无安全性顾虑。

研究设计与样本

  • 基于西班牙加泰罗尼亚2017至2023年前瞻性强制人群登记(Code Stroke)的分析,纳入578例大血管闭塞伴同侧颈内动脉≥50%粥样硬化性狭窄并接受血管内治疗的患者,平均年龄70.2岁,女性140例(24.2%),其中344例(59.5%)接受eCAS。

主要发现

  • eCAS与90天功能结局改善相关(mRS评分降低1分的共同比值比[cOR]为1.47,95%CI 1.20-1.82,p<0.001),1年随访结果相似(cOR 1.47,95%CI 1.16-1.85,p=0.001)。
  • eCAS与更高的成功再通率相关(OR 4.28,95%CI 2.61-7.0,p<0.001),且不增加出血转化风险或90天死亡率。
  • eCAS的获益在中度(50%-69%)和重度(≥70%)颈内动脉狭窄亚组中一致。
  • eCAS组中24小时内接受双联抗血小板治疗的患者良好功能结局比例更高(54.6% vs 22.9%,p<0.001)。
  • 在女性和老年患者中观察到潜在的治疗效应差异。

关键数值与推荐

  • 主要结局为90天和1年改良Rankin量表(mRS)评分的移位,采用逆概率治疗加权校正。
  • 次要结局包括成功再通(改良脑梗死溶栓分级≥2b)、90天良好功能结局(mRS 0-2)、出血转化和90天死亡率。

临床怎么用

  • 对于急性缺血性卒中串联病变接受血管内治疗的患者,急诊颈动脉支架置入可作为改善功能结局的选择,即使对中度颈动脉狭窄患者也可考虑。
  • 术后24小时内启动双联抗血小板治疗可能与更好的功能结局相关。

局限性

  • 观察性设计,可能存在未测量的混杂因素。
  • 女性和老年患者中eCAS的差异效应机制尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Management of carotid lesions during endovascular therapy (EVT) in patients with acute ischemic stroke (AIS) due to tandem lesions (TL) remains controversial, and long-term prognosis data are scarce. We evaluated 90-day and 1-year follow-up outcomes of emergent carotid artery stenting (eCAS) vs non-eCAS in these patients. METHODS: Data from a prospective mandatory population-based registry of Code Stroke in Catalonia (Spain) between 2017 and 2023 were analyzed. Patients with large vessel occlusion and ipsilateral ≥50% atheromatous cervical internal carotid artery (ICA) stenosis undergoing EVT were identified. eCAS and non-eCAS groups were compared. The primary outcome was the shift in the modified Rankin Scale (mRS) score at 90 days and 1 year of follow-up, adjusted using inverse probability of treatment weighting. Stratified analyses in predefined key subgroups according to sex, age, degree of ICA stenosis, Alberta Stroke Program Early CT Score, baseline NIH Stroke Scale, and previous IV thrombolysis were performed. Secondary outcomes included successful recanalization (modified Thrombolysis In Cerebral Infarction ≥2b), 90-day favorable functional outcome (mRS 0-2), hemorrhagic transformation (HT), and 90-day mortality. RESULTS: Among 578 patients included (mean age 70.2 years old, 140 [24.2%] women), 344 patients (59.5%) underwent eCAS. eCAS was associated with a better functional outcome at 90 days (common odds ratio [cOR] for a 1-point less on the mRS score 1.47, 95% CI 1.20-1.82, p < 0.001) and 1 year of follow-up (cOR of 1.47, 95% CI 1.16-1.85, p = 0.001), and with higher successful recanalization rates (OR 4.28, 95% CI 2.61-7.0, p < 0.001), without increasing HT risk or mortality. The benefit of eCAS was consistent in both moderate (50%-69%) and severe (≥70%) ICA stenosis subgroups. Among the eCAS group, patients under dual antiplatelet therapy at 24 hours showed higher rates of favorable functional outcome (54.6% vs 22.9%, p < 0.001). Potential treatment effect differences were observed for women and older patients. DISCUSSION: In this population-based study of patients with AIS due to TL, eCAS was associated with a better mid-term and long-term functional outcome without safety concerns, even in moderate ICA stenosis. Limitations include the observational design and possible unmeasured confounders. Further studies are needed to explore the mechanisms underlying the differential effects of eCAS in women and older patients. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with AIS and TL undergoing EVT, eCAS is associated with favorable functional outcome at 90 days compared with EVT alone.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ezcurra-Díaz G, Cardona P, Rodriguez-Villatoro N, et al. Emergent Carotid Artery Stenting in Patients With Acute Ischemic Stroke With Tandem Lesions: One-Year Follow-Up Results From the SECURIS Study. Neurology. 2025. PMID: 40939130. doi:10.1212/WNL.0000000000214067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。